News
-
Certain types of chemotherapy cause a greater degree of nerve damage than was previously thought (PhD conferral Tonneke Beijers).
-
Mike Gerards is currently working at The Maastricht Centre for Systems Biology (MaCSBio). His project focuses on the identification and functional characterization of novel genes involved in mitochondria (more specifically in mtDNA replication) and screening these genes for mutations in patients.
-
Children of parents with a mental illness or substance abuse problems (abbreviated as COPMI and COSAP, respectively) have a high risk (50–66%) of developing the same problems. This has an impact on their health, wellbeing, social network and overall functioning.
-
People with impaired kidney function have a higher risk of developing memory problems and even dementia, according to an analytic study by researchers Kay Deckers and Sebastian Köhler. Both researchers work at Maastricht University's Alzheimer Centre Limburg (ACL).
-
MODINT, AMIBM and CHILL have pulled together to set up an open innovation center for research into the development of fibers and yarns from biopolymers. The center will develop new textile production processes and –applications for this.
-
On 13 December, the Netherlands Organisation for Scientific Research (NWO) announced the research facilities that will be given highest priority status over the next four years in the Netherlands. Four facilities at Maastricht University, one of which shared by several clusters, are participating in the life science division of the National Roadmap for Large-Scale Scientific Infrastructure developed by the NWO.
-
The selective withdrawal of red blood cells as a treatment for haemochromatosis (iron overload) is an effective and patient-friendly alternative to phlebotomy (bloodletting) (PhD conferral Eva Rombout).
-
On 9 December 2016, leading politicians, scholars and interested parties followed the invitation of the municipality of Maastricht to attend the 25th anniversary of the Maastricht Treaty.